cAMP-phosphodiesterase 4 (PDE4) inhibitors have relaxation effects on bronchochial smooth muscle and anti-inflammatory activities, and have attracted attention as a remedy for asthmatic patients.
Previous work in this series has shown that heterocycle condensed purines, namely tetrahydro-imidazo[2,1-i]purine (1) 9) and (2), 10) were effective for reducing the side effects of xanthines, and it became desirable to determine the effect of other condensed purines on PDE4 inhibitory activity.
As a continuation of studies on [g,h]-condensed purines (3), 11) we have designed and synthesized a series of heterocycles [a]-(4), [b] - (5) , [c,d ] - (6) , and [i]-condensed purines (7, 8) fixing the propyl group 12) as a substituent on the imidazole N atom, and examined their in vitro effects on PDE isoenzymes.
Chemistry
[a]-Condensed purines (4) were prepared according to the method of Nagamatsu et al. 13) Treatment of 9 with propanal and sodium cyanoborohydride gave 5-(propylamino)imidazole (10) , which was treated with benzoylisothiocyanate to give 11. Cyclization of 11 in aq. NaOH yielded 12. Successive S-methylation of 12, treatment of 13 with aminoalcohol, and ring closure of 14 with thionyl chloride gave the [a]-condensed purines (4a, b). N-Propylation of 4a, b afforded 4c and 4d, respectivery (Chart 3).
[b]-Condensed purines (5) were prepared according to the method of Ahn et al. 14) 7-Benzyl-1-propylxanthine (17) , which was obtained from regioselective benzylation 15) of 5,6-diamino-3-propyluracil (15) 16) and ring closure of 16 with diethoxymethyl acetate, was treated with excess phosphorus oxychloride to give 7-benzyl-2-chloropurine (18) . By treatment of 18 with aminoalcohols and subsequent ring closure of 19a, b with thionyl chloride, the corresponding [b]-condensed purines (20a, b) were obtained. Debenzylation of 20 by catalytic hydrogenation afforded the desired 5a, b, which were alkylated with n-propyl bromide in the presence of potassium carbonate to give 5c, d (Chart 4).
[c,d]-Condensed purines (6) were prepared according to the method of Simo et al. 17) Catalytic hydrogenation of nitropyrimidines (21a, b) 18) gave diamines (22a, b), which were treated with ethyl orthoformate without purification to give the [c,d]-condensed purines (6a, b), respectively. N-propylation of 6a, b with n-propyl bromide in the presence of potassium carbonate yielded 6c, d (Chart 5).
Substituted [i]-condensed purines (7, 8) were prepared according to our reported method. 9) 6-(Hydroxyethylamino)-purines (dl-24, dl-25, dl-27 and dl-28) were obtained respec-tively from reaction between 6-chloro-3,7-dipropylxanthine (23) or 3-propyl-6-(1,2,4-triazol-4-yl)purine (26) with each of dl-1-amino-2-propanol and dl-2-amino-1-propanol. dl-24, dl-25, dl-27 and dl-28 were reacted with methanesulfonyl chloride in the presence of triethylamine to give dl-7a, dl-8a, dl-7b and dl-8b, respectively. N-Propylation of dl-7b and dl8b with n-propyl bromide in the presence potassium carbonate afforded dl-7c and dl-8c, respectively (Chart 6).
Results and Discussion
The inhibitory activities of the heterocycle condensed purines (4-8) against PDE1 and PDE4 isoenzymes from guinea-pig brain and PDE3 from guinea-pig heart were measured according to the published methods. 9) The results are shown in Table 1 together with the PDE inhibitory activities of 1, 2, 3, XT-44, DBF and rolipram, reported already. 19) All newly prepared condensed purines showed no or only weak inhibitory activities against PDE1 and PDE3 isoenzymes. Against the PDE4 isoenzyme, the conclusions shown below were drawn. 3. N-propyl substituted [i]-condensed purines (dl-7a, c and dl-8a, c) having a methyl group at the 7-or 8-position, although they caused a decline in selectivity, exert more influence on the PDE4 inhibitory activities than 1 and 2.
In conclusion, dl -3,4-dipropyl-8-methyl-4,5,7,8 -dihydro-1H-imidazo[2,1-i]purine-5-one (dl-7c) exhibited comparable PDE4 inhibitory activity to the known PDE4 inhibitors, rolipram and DBF. An earlier paper 9) has shown that the intramolecular interaction between the alkyl group at the 1-position and the carbonyl group at the 6-position of the xanthine skeleton may be important to elicit selectivity. This observation also suggests that the dihydroimidazole ring moiety of [i]-condensed purine may be important for PDE4 inhibitory activity. Currently, we are investigating the synthesis and PDE4 inhibitory activity of enantiomers of racemic heterocycle [i]-condensed purines (dl-7a, c).
Experimental
Melting points were measured on a Yanagimoto micro melting point hot stage apparatus and are uncorrected. Infrared spectra (IR) were determined with a Horiba FT-720 spectrometer or a Hitachi 270-30 spectrometer. Mass spectra (MS) were measured with JEOL-DX300 instrument. Nuclear magnetic resonance spectra ( 1 H-NMR) were recorded on a JEOL EX 90A spectrometer. Chemical shifts are quoted in parts per million (ppm) with tetramethyl silane as an internal standard. Tables 2 and 3, respectively. 5-Propylaminoimidazole-4-carboxamide (10) To a solution of 5-aminoimidazole-4-carboxamide hydrochloride 9 (1.0 g, 6.2 mmol) in MeOH (10 ml) was added sodium cyanoborohydride (0.31 g, 4.9 mmol) and propional (0.43 g, 7.4 mmol), the reaction mixture was stirred for 24 h at room temperature (rt), then filtered, and evaporated in vacuo. The residue was chromatographed on silica gel using CHCl 3 -MeOH (6 : 1) as an eluent to give 10 (0.66 g, 64%)), which was recrystallized from CHCl 3 
5-[N-(Benzoylthiocarbamoyl)-N-propylamino]imidazole-4-carboxamide (11)
To a suspension of 10 (0.66 g, 3.9 mmol) in CH 2 Cl 2 (15 ml) was added dropwise benzoylisothiocyanate (0.77 g, 4.7 mmol), the reaction mixture was stirred for 6 h at rt. The precipitate was filtered and recrystallized from MeOH to give 11 (0.88 g, 68% 2-Methylthio-3-propylpurin-6-one (13) To a solution of 12 (0.64 g, 3.1 mmol) in 2 M NaOH (15 ml) was added dimethyl sulfate (0.46 g, 3.7 mmol), and the reaction mixture was stirred for 1 h at rt, then neutralized with acetic acid. The precipitate was collected by filtration and recrystallized from AcOEt-MeOH to give 13 (0.41 g, 60% 2-(Hydroxyethylamino)-3-propylpurin-6-one (14a) and 2-(Hydroxypropylamino)-3-propylpurin-6-one (14b) A mixture of 13 (0.41 g, 1.8 mmol) and aminoalcohol (5 ml) in pyridine (10 ml) was heated at reflux overnight and then concentrated in vacuo. 
Data are mean of three experiments. 4-Propyl-4,5,6,7-tetrahydro-1H-imidazo[1,2-a]purin-9-one (4a) and 4-Propyl-4,5,6,7-tetrahydro-1H-pyrimido[1,2-a]purin-10-one (4b) A mixture of 14 (0.63 mmol) and SOCl 2 (0.23 g, 1.9 mmol) in CH 2 Cl 2 (30 ml) was stirred for 24 h at rt. The reaction mixture was evaporated in vacuo, and the residue was chromatographed on silica gel using CHCl 3 -MeOH (3 : 1) as an eluent to give 4, which was recrystallized from AcOEt-MeOH.
1,4-Dipropyl-4,5,6,7-tetrahydro-1H-imidazo[1,2-a]purin-9-one (4c) and 1,4-Dipropyl-4,5,6,7-tetrahydro-1H-pyrimido[1,2-a]purin-10-one (4d) To a mixture of 4a or 4b (2.0 mmol) and anhydrous K 2 CO 3 (0.41 g, 2.9 mmol) in N,N-dimethylformamide (DMF, 10 ml) was added propyl bromide (0.37 g, 3.0 mmol), and the mixture was stirred at rt for 10 h then concentrated in vacuo. The residue was chromatographed on silica gel using CHCl 3 -MeOH (20 : 1) as an eluent to give 4c and 4d, which was recrystallized from petroleum ether.
6-Amino-5-(benzylamino)-3-propyluracil (16) A mixture of 15 (3.7 g, 20 mmol) and benzaldehyde (3.2 g, 30 mmol) in H 2 O (150 ml) was stirred for 2 h at rt. The solution was cooled and the benzylidene was separated from the solution. The benzylidene was then hydrogenated over Raney-Ni (2.0 g) in 1 M NaOH (100 ml) at 3 atom for 12 h. After removal of catalyst and concentration the filtrate, then adjusting the pH to 6 with acetic acid, the crude product was recrystallized from EtOH to give 16 (4.10 g, 75% a) Yield of final step and for purified product. b) High resolution MS spectra data. 4 mmol) at 0°C and stirred for 12 h at rt. The reaction mixture was adjusted to pH 7-8 with 4 M NaOH. The CH 2 Cl 2 layer was washed with brine, dried and concentrated. The residue was chromatographed on silica gel using CHCl 3 -MeOH (10 : 1) as an eluent to give 20, which was recrystallized from iso-propylether. Propyl-5,6,7,8-tetrahydro-3H-pyrimido[2,1-b]purine-4-one (5b) A mixture of 20 (0.81 mmol) and 20% palladium hydroxide on carbon (0.25 g) in MeOH (30 ml) was shaken under hydrogen (3 atom) for 24 h. The catalyst was removed and the filtrate was concentrated in vacuo, and the residue was recrystallized from AcOEt-MeOH to yield 5. 5,6,7,8-tetrahydro-3H-pyrimido[2,1-b] purine-4-one (5d) To a mixture of 5a or 5b (1.7 mmol) and anhydrous K 2 CO 3 (0.35 g, 2.5 mmol) in DMF (10 ml) was added propyl bromide (0.31 g, 2.5 mmol) and the mixture was stirred at rt for 10 h, then concentrated in vacuo. The residue was chromatographed on silica gel using CHCl 3 -MeOH (20 : 1) as an eluent to give 5c or 5d, which was recrystallized from petrolum ether. 10H-diazepino[1,2,3-c,d ]purine-9,11-dione (6b) A suspension of 21 (4.6 mmol) in H 2 O (100 ml) was hydrogenated over 10% palladium on carbon (0.15 g) at 3 atom for 15 h. The catalyst was removed and the filtrate was concentrated in vacuo. A mixture of the residue, DMF (20 ml), triethyl orthoformate (1.1 g, 7.5 mmol) and p-toluenesulfonic acid (0.050 g) was stirred overnight at 100°C. The reaction mixture was then concentrated in vacuo and the residue was chromatographed on silica gel using CHCl 3 -MeOH (3 : 1) as an eluent to give 6, which was recrystallized from EtOH. 5-dihydro-10H-diazepino[1,2,3-c,d ]purine-9,11-dione (6d) A mixture of 6a or 6b (6.0 mmol) and anhydrous K 2 CO 3 (1.5 g, 12 mmol) and propyl bromide (1.6 g, 12 mmol) in DMF (20 ml) was stirred overnight at 60°C. The reaction mixture was concentrated in vacuo and the residue was chromatographed on silica gel using CHCl 3 -MeOH (10 : 1) as an eluent to give 6c or 6d, which was recrystallized from AcOEt-MeOH.
Benzyl-2-(hydroxyproylamino)-1-propylpurin-6-one (19b)
dl-6-[(2-Hydroxy-1-methyl)ethylamino]-3,7-dipropylpurin-2-one (dl-24) To 23 (0.51 g, 2.0 mmol) in pyridine (10 ml) was added dl-2-amino-1-propanol (4 ml) and the mixture was refluxed overnight. The reaction mixture was evaporated in vacuo and the residue was chromatographed on silica gel using CHCl 3 -MeOH (3 : 1) as an eluent to give dl-24 (0.39 g, 83% 
